Search results for "antidepressant"

showing 10 items of 161 documents

Effects of different doses of doxepin on passive avoidance learning in rats

2013

Background: Studies have shown that Doxepin has anti-inflammatory effects and reduces oxidative stress. Due to the fact that other tricyclic antidepressants have been shown to have neuroprotective effects, this study aimed to investigate the effects of different doses of doxepin on passive avoidance learning in rats. Materials and Methods: Old male Wistar rats were used in this study. Doxepin was administered intraperitoneally (1, 5 and 10 mg/kg) for 21 days. Passive avoidance learning test was used for evaluation of learning and memory. Rats received foot electrical shock on fifteen day, and step through latencies were evaluated one week after the electrical shock in retention phase. Resul…

medicine.drug_classTricyclic antidepressantlcsh:MedicinePharmacologymedicine.disease_causeNeuroprotectiontricyclic antidepressantmedicineratlcsh:QH301-705.5chemistry.chemical_classificationbusiness.industryLow doselcsh:RElectrical shockGeneral MedicineDoxepinchemistrylcsh:Biology (General)AnesthesiaOriginal ArticleDoxepinPassive avoidancelearning and memorybusinessOxidative stressTricyclicmedicine.drugAdvanced Biomedical Research
researchProduct

Paroxetine Administration Affects Microbiota and Bile Acid Levels in Mice.

2020

Recent interest in the role of microbiota in health and disease has implicated gut microbiota dysbiosis in psychiatric disorders including major depressive disorder. Several antidepressant drugs that belong to the class of selective serotonin reuptake inhibitors have been found to display antimicrobial activities. In fact, one of the first antidepressants discovered serendipitously in the 1950s, the monoamine-oxidase inhibitor Iproniazid, was a drug used for the treatment of tuberculosis. In the current study we chronically treated DBA/2J mice for 2 weeks with paroxetine, a selective serotonin reuptake inhibitor, and collected fecal pellets as a proxy for the gut microbiota from the animals…

medicine.drug_classlcsh:RC435-571Serotonin reuptake inhibitorClinical SciencesmicrobiomeGut floraPharmacology03 medical and health sciences0302 clinical medicineRare Diseaseslcsh:PsychiatrymedicinePsychologyMicrobiomeCancerOriginal ResearchPsychiatrybile acidsantidepressantbiologyBile acidbusiness.industryDepressionbiology.organism_classificationmedicine.diseaseParoxetinemetabolomics030227 psychiatryColo-Rectal CancerPsychiatry and Mental healthMental HealthGood Health and Well Being5.1 PharmaceuticalsPublic Health and Health ServicesAntidepressantDevelopment of treatments and therapeutic interventionsbusinessDigestive DiseasesDysbiosis030217 neurology & neurosurgeryBehavioural despair testmedicine.drugparoxetineFrontiers in psychiatry
researchProduct

Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis.

2018

Background: Treatment-emergent mania (TEM) represents a common phenomenon inconsistently reported across primary studies, warranting further assessment. Methods: A systematic review and meta-analysis following the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) and Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines were conducted. Major electronic databases were searched from inception to May 2017 to assess the incidence and prevalence rates and clinical features associated with manic switch among bipolar depressed patients receiving antidepressants, using meta-regression and subgroup analysis. Results: Overall, 10 098 depressed patients wit…

medicine.medical_specialtyBipolar DisorderSubgroup analysismeta-analysinot knownlaw.invention03 medical and health sciences0302 clinical medicineantidepressant; bipolar disorder; incidence; meta-analysis; switch; systematic reviewsystematic reviewRandomized controlled triallawInternal medicinemedicinePrevalenceHumansCumulative incidenceBipolar disorderBiological Psychiatryantidepressantbusiness.industryDepressionIncidence (epidemiology)Incidencemedicine.diseaseswitchConfidence intervalAntidepressive Agents030227 psychiatrymeta-analysisPsychiatry and Mental healthMeta-analysismedicine.symptombusinessMania030217 neurology & neurosurgeryBipolar disorders
researchProduct

Characteristics of bipolar disorder patients given antidepressants

2012

Evidence concerning efficacy of antidepressants in bipolar disorder remains inconsistent and inconclusive. As the appropriate clinical use for such patients remains unclear, we characterized outpatients with bipolar disorders who were or were not treated with antidepressants. Clinical data were collected systematically from consecutive outpatients in 11 participating Argentine mood-disorder clinics in 2007–2008. Diagnoses met DSM-IV criteria, supported by structured interviews based on the MINI-500. Of 338 outpatients diagnosed with bipolar I (45.0%), II (29.3%), or not-otherwise-specified (NOS) (25.7%) disorder, 128 (37.9%) received antidepressants. Subjects given antidepressants or not di…

medicine.medical_specialtyBipolar I disorderbusiness.industrymedicine.diseaseAntimanic AgentsPsychiatry and Mental healthNeurologyInternal medicineMedicineOutpatient clinicAntidepressantPharmacology (medical)Neurology (clinical)Bipolar disorderbusinessPsychiatryDepression (differential diagnoses)Human Psychopharmacology: Clinical and Experimental
researchProduct

P-515 - CGI Rating to predict antidepressant treatment under naturalistic conditions

2012

Introduction Recent studies have shown that psychopathological rating by the Hamilton Depression Rating scale (HAMD) is well established and highly predictive for later response. In this study we aimed to find out if Clinical Global Impression (CGI) scale is suitable to guide antidepressive treatment under naturalistic conditions. Methods Inpatients with a major depressive disorder and treatment with citalopram were included and rated using in parallel the HAMD scale and the CGI scale weekly at baseline to day 35. According to CGI the sample has been divided in “CGI improver” (CGI = 2–4) and “CGI non-improver” (CGI = 5–6). Response was defined as HAMD sum score reduction by at least 50%. Re…

medicine.medical_specialtyCitaloprammedicine.diseasehumanitiesPsychiatry and Mental healthRating scalehealth services administrationInternal medicinemental disordersHamdClinical Global ImpressionmedicineMajor depressive disorderAntidepressantPsychiatryPsychologyPsychopathologymedicine.drugEuropean Psychiatry
researchProduct

Childhood maltreatment and clinical severity of treatment‐resistant depression in a French cohort of outpatients (FACE‐DR): One‐year follow‐up

2020

International audience; Childhood maltreatment is associated with major depressive disorder (MDD). It not only increases the risk of lifetime MDD, but it also aggravates its course. Among depressed patients, 20-30% of them experience treatment-resistance depression (TRD). We aimed to assess the association between childhood maltreatment, severity of depression in a unipolar TRD sample, and patient outcomes after one-year of follow-up. Methods: Patients were recruited for a prospective cohort from the French network of TRD expert centers. Depressive symptom severity was assessed with the Montgomery-Åsberg Depression Rating Scale (MADRS) and the Quick Inventory of Depressive Symptomatology se…

medicine.medical_specialtyDepressive disordersMESH: DepressionPopulationMESH: Depressive Disorder MajorPoison controlChildhood trauma03 medical and health sciences0302 clinical medicineInternal medicineSurveys and QuestionnairesMESH: ChildOutpatientsmedicineHumansChild AbuseProspective StudiesMESH: Surveys and QuestionnaireseducationProspective cohort studyChildChildhood neglecteducation.field_of_studyDepressive Disorder Major[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/PediatricsMESH: Humansbusiness.industryDepressionAntidepressant responseChildhood abuseCTQ treeMESH: Follow-Up StudiesMESH: Child Abusemedicine.diseaseMESH: Prospective Studies3. Good health030227 psychiatryMESH: OutpatientsPsychiatry and Mental healthClinical PsychologySexual abuse[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthCohortMajor depressive disorderTreatment-resistant depressionbusinessTreatment-resistant depression030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

Pharmacologic management of neuropathic pain: Evidence-based recommendations

2007

Patients with neuropathic pain (NP) are challenging to manage and evidence-based clinical recommendations for pharmacologic management are needed. Systematic literature reviews, randomized clinical trials, and existing guidelines were evaluated at a consensus meeting. Medications were considered for recommendation if their efficacy was supported by at least one methodologically-sound, randomized clinical trial (RCT) demonstrating superiority to placebo or a relevant comparison treatment. Recommendations were based on the amount and consistency of evidence, degree of efficacy, safety, and clinical experience of the authors. Available RCTs typically evaluated chronic NP of moderate to severe …

medicine.medical_specialtyGabapentinHealth Planning GuidelinesAnalgesicPregabalinPainPlacebolaw.inventionRandomized controlled triallawMedicineAnimalsHumansIntensive care medicineEvidence-Based Medicinebusiness.industryAnesthesiology and Pain MedicineNeurologyAnesthesiaNeuropathic painAntidepressantNeuralgiaNeurology (clinical)Tramadolbusinessmedicine.drug
researchProduct

Influence of gender on cytokine induced depression and treatment

2021

Abstract Background Cytokine treatment with Interferon-alpha (IFN-α) represents a clinical model of immune associated depression, but it remains unclear if it is of the same entity as major depressive disorder (MDD). The study focuses on possible gender differences in IFN-α induced depression and effects of a pre-emptive antidepressant treatment. Methods Data from 181 patients with chronic hepatitis C infection (cHC) without history of mental illnesses undergoing treatment with IFN-α 2a and ribavirin were re-analyzed for gender effects. Patients with a pre-emptive antidepressant therapy with Escitalopram (n = 90, verum group) to prevent IFN-induced depression were compared to patients who r…

medicine.medical_specialtyHamilton Anxiety Rating Scalebusiness.industryAlpha interferonmedicine.diseasePlacebo030227 psychiatry03 medical and health sciencesPsychiatry and Mental healthClinical Psychology0302 clinical medicineRating scaleInternal medicinemedicineMajor depressive disorderAntidepressantEscitaloprambusiness030217 neurology & neurosurgeryDepression (differential diagnoses)medicine.drugJournal of Affective Disorders
researchProduct

Antidepressant Effects of Exercise: A Role for the Adiponectin-PGC-1α-kynurenine Triad?

2015

It is well-recognized that exercise improves mental health, e.g., by decreasing depressive behaviors, improving hippocampal-dependent learning and neurogenesis, and increasing dendritic plasticity. Yet how exercise influences the brain at the molecular level is not clearly understood. Yau et al recently reported that the antidepressant effects of physical exercise are mainly mediated by adiponectin, an adipocyte-secreted hormone ('adipocytokine') with neuroprotective effects at the central nervous system level (Yau et al., 2014). 4.155 JCR (2015) Q1, 12/83 Physiology; Q2, 63/187 Cell biology UEM

medicine.medical_specialtyPhysiologyClinical BiochemistrySaludchemistry.chemical_compoundTriad (sociology)Internal medicinemedicineAnimalsHumansExercise physiologyMuscle SkeletalEducación físicaExerciseKynurenineAdiponectinbusiness.industryKynurenine metabolismCell BiologyEjercicio físicoEndocrinologychemistryAntidepressantAdiponectinbusinessKynurenineTranscription FactorsJournal of Cellular Physiology
researchProduct

Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis.

2017

Objective: Deficiency of acetyl-l-carnitine (ALC) seems to play a role in the risk of developing depression, indicating a dysregulation of fatty acid transport across the inner membrane of mitochondria. However, data about ALC supplementation in humans are limited. We thus conducted a systematic review and meta-analysis investigating the effect of ALC on depressive symptoms across randomized controlled trials (RCTs). Methods: A literature search in major databases, without language restriction, was undertaken from inception until 30 December 2016. Eligible studies were RCTs of ALC alone or in combination with antidepressant medications, with a control group taking placebo/no intervention or…

medicine.medical_specialtyPlacebonot knownlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineMedicineHumansAdverse effectApplied PsychologyDepression (differential diagnoses)Randomized Controlled Trials as Topicbusiness.industryDepressionIncidence (epidemiology)Confidence intervalAntidepressive Agents030227 psychiatryPsychiatry and Mental healthMeta-analysisDietary SupplementsVitamin B ComplexAntidepressantbusinessAcetylcarnitine030217 neurology & neurosurgeryPsychosomatic medicine
researchProduct